Wikipedia -WSS

Wikipedia

author：leisure time 2025-10-02 00:19:25 - browse：1

A photo of Robert Blum speaking at the STAT Summit West on May 16, 2024 — Cytokinetics CEO Robert Blum spoke last week at a talk during STAT’s Breakthrough Summit West in San Francisco. Sarah Gonzalez for STAT

Cytokinetics, a drugmaker that is expected to soon launch a promising new heart therapy called aficamten, said Wednesday that it had agreed to pay biotech firm Royalty Pharma a higher royalty on the medicine in return for up to $575 million, which will be used to fund the marketing of the drug and Cytokinetics’ ongoing research and development efforts.

Cytokinetics shares fell nearly 10% in after-hours trading after the announcement, which investors viewed as lowering the odds that the company will be purchased by a larger pharmaceutical company.

The firm also said that it would be raising $500 million through a stock sale.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： FDA approval of Sarepta Duchenne genetic therapy gives me hope
Next article： Bernie Sanders gets little from pharma CEOs on drug prices

hotspot

WSS

Study gives hint on South Asians’ higher risk of cardiovascular disease

Resistance to opioid

Readout Newsletter: Replicate, Biogen's Leqembi, and Humira

Having children helps parents live longer, especially after age 80

Long Covid research funding gets a major boost from NIH

Readout Newsletter: Amylyx, Aurinia, and IQVIA

hotspot

Wikipedia

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

hotspot

Activists slam private health insurers over coverage restrictions

Make 'food is medicine' a key part of White House nutrition meeting

Drug repurposing or repositioning? The language matters

Study gives hint on South Asians’ higher risk of cardiovascular disease

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

4 killed, 7 hurt in mass shooting at July 4 block party in Louisiana; no arrests made

At least 13 dead in Texas as scorching temps continue

STAT Boddities: What happens to the brain when we get scared?

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

STAT Boddities: What happens to the brain when we get scared?

knowledge

Listen: PBM conflicts, RSV vaccines, & the future of flu season

Pfizer's Covid pill remains 89% effective in final analysis, company says

Artificial intelligence use in health care faces greater scrutiny in 2024

Readout Newsletter: Replicate, Biogen's Leqembi, and Humira

Abbott's new heart device gets FDA advisory panel nod

Option Care buys Amedisys in $3.6 billion home care deal

hotspot

hotspot

hotspot

hotspot